• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1

CATEGORIES

  • 5
  • 4
  • 4
  • 1

PRICE

3
3
5
14

PUBLISHED

0
2
12
14

PRODUCT TYPE

10
3
1

Search "Dicerna Pharmaceuticals, Inc.-Detailed Product Pipeline" returned 14 results.

PRODUCT TITLE

Dicerna Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Dicerna Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Dicerna Pharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the Dicerna...

July 2014
FROM

Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma

“Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma” provides insights into the unmet needs in the pharmaceutical and healthcare market and potential segments where...

February 2010
FROM

Tekmira Pharmaceuticals Corp. (TKM) - Financial and Strategic SWOT Analysis Review

Tekmira Pharmaceuticals Corp. (TKM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

June 2014
FROM
Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review

Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review Summary Alnylam Pharmaceuticals, Inc., (Alnylam) is a biopharmaceutical company focusing on the discovery, development...

April 2012
FROM

Hepatocellular Carcinoma - Pipeline Review, H1 2014

Hepatocellular Carcinoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2014’, provides an overview of the Hepatocellular Carcinoma’s therapeutic...

May 2014
FROM

Refractory Multiple Myeloma - Pipeline Review, H1 2015

Refractory Multiple Myeloma - Pipeline Review, H1 2015 Summary This, ‘Refractory Multiple Myeloma - Pipeline Review, H1 2015’, provides an overview of the Refractory Multiple Myeloma’s therapeutic...

January 2015
FROM

Refractory Multiple Myeloma - Pipeline Review, H2 2014

Refractory Multiple Myeloma - Pipeline Review, H2 2014 Summary This, ‘Refractory Multiple Myeloma - Pipeline Review, H2 2014’, provides an overview of the Refractory Multiple Myeloma’s therapeutic...

July 2014
FROM

Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2014

Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2014 Summary This, ‘Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2014’, provides an overview of the Alpha- Antitrypsin Deficiency’s therapeutic...

November 2014
FROM

Non-Hodgkin Lymphoma - Pipeline Review, H2 2014

Non-Hodgkin Lymphoma - Pipeline Review, H2 2014 Summary This, ‘Non-Hodgkin Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline. This report...

October 2014
FROM

Hepatocellular Carcinoma - Pipeline Review, H2 2014

Hepatocellular Carcinoma - Pipeline Review, H2 2014 Summary This, ‘Hepatocellular Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Hepatocellular Carcinoma’s therapeutic pipeline. This...

November 2014
FROM

Global RNA Based Therapeutics Market (Technology, Application, End Users and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

RNA based therapeutics has garnered significant attention in the recent years due to its potential to treat variety of chronic diseases such as cancer, diabetes, AIDS, Tuberculosis and certain cardiovascular...

September 2014
FROM

Marina Biotech, Inc. (MRNA) - Financial and Strategic SWOT Analysis Review

Marina Biotech, Inc. (MRNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

May 2014
FROM

Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2015

Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2015 Summary This, ‘Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2015’, provides an overview of the Alpha- Antitrypsin Deficiency’s therapeutic...

February 2015
FROM

Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2014

Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2014’, provides an overview of the Alpha- Antitrypsin...

June 2014
FROM
Loading Indicator

Our Clients

Goodyear Tire & Rubber Company GlaxoSmithKline PLC Hilton Worldwide Hewlett-Packard Company Accenture PLC. Qualcomm Incorporated UBS AG